-
公开(公告)号：US20220411528A1
公开(公告)日：2022-12-29
申请号：US17744262
申请日：2022-05-13
Applicant: Genentech, Inc.
Inventor： Carol Elaine O'HEAR , Yasuhiro OKI , Iris Tranthuyngan TO
Abstract: The present invention relates to the treatment of subjects having a CD20-positive cell proliferative disorder. More specifically, the invention pertains to the treatment of subjects having a CD20-positive cell proliferative disorder by administering a combination of mosunetuzumab and polatuzumab vedotin.
Search Results
1
records
(took 0.01 seconds)
筛选
AND
AND
过滤
NOT
NOT
Scan to Join
